NCT06376227

Brief Summary

Brief Summary Background The preservation of the left colic artery (LCA) during rectal cancer resection remains a topic of controversy, and there is a notable absence of robust evidence regarding the outcomes associated with LCA preservation. And the advantages of robotic-assisted laparoscopy (RAL) surgery in rectal resection remain uncertain. The objective of this study was to assess the influence of LCA preservation surgery and RAL surgery on intraoperative and postoperative complications of rectal cancer resection. Methods Participants who underwent laparoscopic (LSC) or RAL with or without LCA preservation resection for rectal cancer between April 2020 and May 2023 were retrospectively assessed. The patients were categorized into two groups: low ligation (LL) which with preservation of LCA and high ligation (HL) which without preservation of LCA. A one-to-one propensity score-matched analysis was performed to decrease confounding. The primary outcome was operative findings, operative morbidity, and postoperative genitourinary function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,164

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 19, 2024

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

3.2 years

First QC Date

April 10, 2024

Last Update Submit

April 19, 2024

Conditions

Keywords

Rectal cancerLeft colic arteryHigh ligationLow ligationInferior mesenteric arteryRobotic-assisted laparoscopy

Outcome Measures

Primary Outcomes (1)

  • The incidence of anastomotic leakage in postoperative patients with or without left colic artery preservation.

    Within two weeks after surgery, the patient experienced abdominal pain, fever, and imaging diagnosis showed anastomotic leakage.

    2 weeks within the surgery

Secondary Outcomes (1)

  • The genitourinary function of the patients after the radical resection with or without left colic artery preservation.

    6 to 12 months after operation

Study Arms (2)

with or without Left Colic Artery Preservation

low ligation (LL) group and high ligation (HL) group

low ligation (LL) which with preservation of LCA and high ligation (HL) which without preservation of LCA

Procedure: with or without Left Colic Artery Preservation

Interventions

low ligation (LL) which with preservation of LCA and high ligation (HL) which without preservation of LCA

low ligation (LL) group and high ligation (HL) group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 612 rectal cancer patients, including 245 (40.0%) men and 367(60.0%) women, were enrolled in this study.

You may qualify if:

  • Low anterior resection for rectal cancer
  • Postoperative pathological diagnosis of rectal adenocarcinoma
  • Informed consent signed prior to surgery.

You may not qualify if:

  • Recurrent rectal cancer
  • Emergency surgery
  • Preoperative and intraoperative detection of distant organ metastases or extensive
  • Implantation metastases in the abdominal cavity
  • Palliative surgery
  • A postoperative pathology report that showed residual cancer cells at the proximal or distal resection margin
  • No standard chemotherapy for tumor-node-metastasis (TNM) staging II or III after surgery
  • Synchronous colorectal carcinoma and other organ tumors
  • Incomplete case data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northern Jiangsu People's Hospital Affiliated to Yangzhou University, General Surgery Institute of Yangzhou, Yangzhou University , Yangzhou

Yangzhou, Jiangsu, 225001, China

Location

MeSH Terms

Conditions

Rectal NeoplasmsDisease

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Daorong Wang, M.D., Professor

    Northern Jiangsu People's Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 10, 2024

First Posted

April 19, 2024

Study Start

April 1, 2020

Primary Completion

May 31, 2023

Study Completion

December 28, 2023

Last Updated

April 22, 2024

Record last verified: 2024-04

Locations